Takeda Pharmaceutical Co Financial Overview
Takeda Pharmaceutical Co's market cap is currently $49.30B. The company's EPS TTM is $-0.05057397; its P/E ratio is 179.14; and it has a dividend yield of 4.28%. Takeda Pharmaceutical Co is scheduled to report earnings on October 30, 2025, and the estimated EPS forecast is $0.34. See an overview of income statement, balance sheet, and cash flow financials.
